Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Chugai Pharmaceutical in the Drug Discovery & Development Pharma 50

Chugai Pharmaceutical (Roche Group)

Rank: 31

2021 Rank: 29

Tokyo, Japan
www.chugai-pharm.co.jp/english/

2021 Revenues ($USD) : $9,101,957,393
2021 Revenues (foreign currencies) : JP¥999,759,000,000
2021 R&D spend : $1,181,718,864
2021 Number of Employees : 7,664
Fiscal Year End : 12/31/2021
Leader : CEO Osamu Okuda

Toko-based Chugai traces its origins back to 1925 with the founding of Chugai Shinyaku Co. Ltd., which began as a pharmaceutical importer. The company started its own drug production in 1927. In 2002, the company forged a strategic alliance with Roche that preserved Chugai’s autonomy while giving it the exclusive right to market Roche's products in Japan. Core drugs in its portfolios include Actemra (tocilizumab), an IL-6 signal blockade agent for rheumatoid arthritis and other autoimmune diseases, as well as Alecensa (alectinib), an ALK inhibitor for non-small cell lung cancer. Another key drug is Hemlibra (emicizumab-kxwh), an anti-factor IXa/X bispecific antibody for hemophilia A co-developed with Roche. —BB

Chugai

[Chugai facility. Image courtesy of F. Hoffmann-La Roche Ltd.]

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE